|Alimera Sciences Inc -- USA Stock|| |
USD 1.38 0.03 2.13%
Co-Founder and Sr. VP of Sales and Marketing
Mr. David R. Holland is the Senior Vice President Sales and Marketing of Alimera Sciences, Inc. Prior cofounders and served as the Vice President of Marketing since the founding of our Company in 2003 through August 2010 when he was appointed the Senior Vice President of Sales and Marketing. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.
Age: 51 Founder Since 2010
David Holland Latest Insider Activity
The company has return on total asset (ROA)
of (19.55) %
which means that it has lost $19.55 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (147.22) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 33.96 M in liabilities with Debt to Equity (D/E) ratio of 156.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Alimera Sciences Inc has Current Ratio of 4.53 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. Alimera Sciences Inc (ALIM) is traded on NASDAQ General Markets in USA. It is located in GEORGIA, U.S.A and employs 125 people. Alimera Sciences is listed under Pharmaceutical Products category by Fama And French industry classification.